1. philip278
2. berdoodle
3. tuba2
1.berdoodle 03/07/2018
Misses EPS loss estimates by $0.35
2.tuba2 03/07/2018
Terminates collaborative development and license agreement with Teva
3.philip278 02/21/2018
Xenon Pharmaceuticals Advances Second Proprietary Epilepsy Product into the Clinic with Initiation of XEN901 Phase 1 Clinical Trial
4.philip278 01/08/2018
Xenon Pharmaceuticals Outlines Key Milestones for 2018
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW